Company / Current Assets per Share
REGENXBIO Inc. Current Assets per Share History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Current Assets per Share
$5.68
FY2025
5-year range
$5.68 / $13.84
FY2021-FY2025
Trend
-10.1%
vs FY2024
Sector context
#126 of 210
Health Care
What the data says
At $5.68, REGENXBIO Inc.'s current assets per share ranks #126 of 210 in the Health Care sector. Current Assets per Share has declined for 5 consecutive years, from $14.36 in FY2020 to $5.68 in FY2025.
Based on SEC 10-K filings.
5.68 in FY2025 with a 5-year CAGR of -16.9%.
Declined from $7.74 to $5.68 over the past 2 years.
Health Care sector context is included.
Current Assets per Share over time
Growth rates
- 3-Year CAGR
- -16.4%
- 5-Year CAGR
- -16.9%
- 10-Year CAGR
- -
Sector benchmark
#126 of 210 in Health CareTop 60% of 210This company $5.68 Sector average $134.38
▼
-95.8% below sector average
Key checks
Key Insights
- REGENXBIO Inc.'s current assets per share has declined for 5 consecutive years.
- In FY2025, current assets per share decreased 10.1% year-over-year.
- Ranks #126 out of 210 companies in the Health Care sector.
- Peak current assets per share was recorded in FY2020.
Company context
Key Data Points
- Altman Z-Score -2.45 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Current Assets per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $5.68 | -10.1% |
| FY2024 | $6.31 | -18.4% |
| FY2023 | $7.74 | -20.3% |
| FY2022 | $9.71 | -29.8% |
| FY2021 | $13.84 | -3.6% |
| FY2020 | $14.36 | +50.3% |
| FY2019 | $9.55 | -11.5% |
| FY2018 | $10.80 | +70.2% |
| FY2017 | $6.35 | +78.8% |
| FY2016 | $3.55 | -92.1% |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026